Clinical significance of performing 18F-FDG PET on patients with gastrointestinal stromal tumors: a summary of a Japanese multicenter study
- 9 May 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Nuclear Medicine
- Vol. 23 (5), 459-464
- https://doi.org/10.1007/s12149-009-0257-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Lessons of GIST—PET and PET/CT: A New Paradigm for ImagingThe Oncologist, 2008
- CT and PET: Early Prognostic Indicators of Response to Imatinib Mesylate in Patients with Gastrointestinal Stromal TumorAmerican Journal of Roentgenology, 2007
- Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response CriteriaJournal of Clinical Oncology, 2007
- Prospective Multicentric Randomized Phase III Study of Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors Comparing Interruption Versus Continuation of Treatment Beyond 1 Year: The French Sarcoma GroupJournal of Clinical Oncology, 2007
- Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced diseaseCurrent Opinion in Gastroenterology, 2007
- Combined Surgical and Molecular TherapyAnnals of Surgery, 2006
- Esophageal Leiomyoma: A Rare Cause of False-Positive FDG ScansClinical Nuclear Medicine, 2006
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorThe New England Journal of Medicine, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomasCancer, 1992